Article Versions Notes

Sanches C, Alves GCS, Farkas A, da Silva SD, de Castro WV, Chequer FMD, Beraldi-Magalhães F, Magalhães IRdS, Baldoni AdO, Chatfield MD, et al. Population Pharmacokinetic Model of Piperacillin in Critically Ill Patients and Describing Interethnic Variation Using External Validation. Antibiotics. 2022; 11(4):434. https://doi.org/10.3390/antibiotics11040434

Sanches, Cristina, Geisa C. S. Alves, Andras Farkas, Samuel Dutra da Silva, Whocely Victor de Castro, Farah Maria Drummond Chequer, Francisco Beraldi-Magalhães, Igor Rafael dos Santos Magalhães, André de Oliveira Baldoni, Mark D. Chatfield, and et al. 2022. "Population Pharmacokinetic Model of Piperacillin in Critically Ill Patients and Describing Interethnic Variation Using External Validation" Antibiotics 11, no. 4: 434. https://doi.org/10.3390/antibiotics11040434

Sanches, C., Alves, G. C. S., Farkas, A., da Silva, S. D., de Castro, W. V., Chequer, F. M. D., Beraldi-Magalhães, F., Magalhães, I. R. d. S., Baldoni, A. d. O., Chatfield, M. D., Lipman, J., Roberts, J. A., & Parker, S. L. (2022). Population Pharmacokinetic Model of Piperacillin in Critically Ill Patients and Describing Interethnic Variation Using External Validation. Antibiotics, 11(4), 434. https://doi.org/10.3390/antibiotics11040434